The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria
Author
Source
Issue
Vol. 2012, Issue 2012 (31 Dec. 2012), pp.1-12, 12 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-06-09
Country of Publication
Egypt
No. of Pages
12
Main Subjects
Natural & Life Sciences (Multidisciplinary)
Biology
Abstract EN
Cerebral malaria is a severe complication of Plasmodium falciparum infection associated with high mortality even when highly effective antiparasitic therapy is used.
Adjunctive therapies that modify the pathophysiological processes caused by malaria are a possible way to improve outcome.
This review focuses on the utility of PPARγ agonists as an adjunctive therapy for the treatment of cerebral malaria.
The current knowledge of PPARγ agonist use in malaria is summarized.
Findings from experimental CNS injury and disease models that demonstrate the potential for PPARγ agonists as an adjunctive therapy for cerebral malaria are also discussed.
American Psychological Association (APA)
Serghides, Lena. 2011. The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria. PPAR Research،Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-477648
Modern Language Association (MLA)
Serghides, Lena. The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria. PPAR Research No. 2012 (2012), pp.1-12.
https://search.emarefa.net/detail/BIM-477648
American Medical Association (AMA)
Serghides, Lena. The Case for the Use of PPARγ Agonists as an Adjunctive Therapy for Cerebral Malaria. PPAR Research. 2011. Vol. 2012, no. 2012, pp.1-12.
https://search.emarefa.net/detail/BIM-477648
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-477648